Corteva, Inc. (NYSE:CTVA) Stake Increased by Aptus Capital Advisors LLC

Aptus Capital Advisors LLC lifted its stake in Corteva, Inc. (NYSE:CTVAFree Report) by 29.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,630 shares of the company’s stock after acquiring an additional 1,977 shares during the period. Aptus Capital Advisors LLC’s holdings in Corteva were worth $442,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of CTVA. NewSquare Capital LLC grew its position in Corteva by 70.6% in the 3rd quarter. NewSquare Capital LLC now owns 546 shares of the company’s stock worth $28,000 after purchasing an additional 226 shares during the last quarter. Glass Jacobson Investment Advisors llc grew its position in Corteva by 234.3% during the third quarter. Glass Jacobson Investment Advisors llc now owns 555 shares of the company’s stock worth $28,000 after buying an additional 389 shares in the last quarter. Cornerstone Planning Group LLC acquired a new stake in Corteva during the second quarter worth about $28,000. Union Savings Bank increased its stake in Corteva by 58.5% during the third quarter. Union Savings Bank now owns 577 shares of the company’s stock valued at $30,000 after acquiring an additional 213 shares during the period. Finally, Blume Capital Management Inc. raised its holdings in Corteva by 103.8% in the 2nd quarter. Blume Capital Management Inc. now owns 542 shares of the company’s stock valued at $31,000 after acquiring an additional 276 shares in the last quarter. Institutional investors own 80.56% of the company’s stock.

Corteva Stock Up 0.7 %

Shares of NYSE CTVA opened at $53.60 on Friday. Corteva, Inc. has a 12-month low of $43.22 and a 12-month high of $64.98. The firm’s 50-day simple moving average is $47.23 and its 200 day simple moving average is $49.14. The company has a quick ratio of 0.90, a current ratio of 1.56 and a debt-to-equity ratio of 0.09. The company has a market cap of $37.77 billion, a price-to-earnings ratio of 52.55, a price-to-earnings-growth ratio of 1.37 and a beta of 0.73.

Corteva (NYSE:CTVAGet Free Report) last announced its earnings results on Thursday, February 1st. The company reported $0.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.06 by $0.09. The company had revenue of $3.71 billion for the quarter, compared to analyst estimates of $3.54 billion. Corteva had a net margin of 4.27% and a return on equity of 7.43%. During the same period in the prior year, the business earned $0.16 earnings per share. On average, research analysts expect that Corteva, Inc. will post 2.87 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 15th. Stockholders of record on Friday, March 1st will be paid a $0.16 dividend. The ex-dividend date of this dividend is Thursday, February 29th. This represents a $0.64 annualized dividend and a dividend yield of 1.19%. Corteva’s dividend payout ratio (DPR) is currently 62.75%.

Analysts Set New Price Targets

CTVA has been the topic of a number of research reports. Barclays boosted their price objective on Corteva from $50.00 to $55.00 and gave the company an “equal weight” rating in a research report on Friday, February 2nd. UBS Group dropped their price objective on shares of Corteva from $65.00 to $64.00 and set a “buy” rating for the company in a research note on Thursday, January 11th. Morgan Stanley decreased their target price on shares of Corteva from $80.00 to $60.00 and set an “overweight” rating on the stock in a research report on Friday, November 10th. The Goldman Sachs Group dropped their price target on shares of Corteva from $65.00 to $56.00 and set a “neutral” rating for the company in a research report on Tuesday, October 24th. Finally, Roth Mkm decreased their price objective on Corteva from $82.00 to $63.00 and set a “buy” rating on the stock in a report on Wednesday, November 22nd. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $62.84.

Get Our Latest Report on Corteva

Insider Transactions at Corteva

In other Corteva news, insider Samuel R. Eathington bought 1,094 shares of Corteva stock in a transaction dated Tuesday, November 28th. The shares were bought at an average price of $46.07 per share, with a total value of $50,400.58. Following the purchase, the insider now owns 41,066 shares of the company’s stock, valued at $1,891,910.62. The transaction was disclosed in a document filed with the SEC, which is available at this link. In related news, EVP Robert D. King acquired 640 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The stock was acquired at an average cost of $46.77 per share, with a total value of $29,932.80. Following the completion of the purchase, the executive vice president now directly owns 59,701 shares in the company, valued at $2,792,215.77. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Samuel R. Eathington bought 1,094 shares of the business’s stock in a transaction on Tuesday, November 28th. The stock was bought at an average cost of $46.07 per share, for a total transaction of $50,400.58. Following the purchase, the insider now directly owns 41,066 shares of the company’s stock, valued at approximately $1,891,910.62. The disclosure for this purchase can be found here. Insiders bought a total of 2,084 shares of company stock worth $95,527 over the last 90 days. 0.14% of the stock is owned by insiders.

Corteva Company Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Further Reading

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.